Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
33%(2 trials)

Phase Distribution

Ph not_applicable
1
13%
Ph phase_3
2
25%
Ph phase_4
3
38%
Ph phase_2
1
13%
Ph phase_1
1
13%

Phase Distribution

1

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
3(37.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(6)
Other(2)

Detailed Status

Completed6
unknown2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (12.5%)
Phase 21 (12.5%)
Phase 32 (25.0%)
Phase 43 (37.5%)
N/A1 (12.5%)

Trials by Status

completed675%
unknown225%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_2

Benfotiamine in Alzheimer's Disease: A Pilot Study

NCT02292238
completednot_applicable

Benfotiamine Effect on Advanced Glycation End Products(AGEs) and Soluble Receptor for AGEs(sRAGE) in Diabetes Mellitus.

NCT02772926
completedphase_4

High Dose Vitamin B1 to Reduce Abusive Alcohol Use

NCT00680121
unknownphase_3

Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)

NCT01868191
completedphase_1

Effects of Vitamin B1 in Type 1 Diabetic Patients

NCT00117026
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT02292238Phase 2

Benfotiamine in Alzheimer's Disease: A Pilot Study

Completed
NCT02772926Not Applicable

Benfotiamine Effect on Advanced Glycation End Products(AGEs) and Soluble Receptor for AGEs(sRAGE) in Diabetes Mellitus.

Completed
NCT00680121Phase 4

High Dose Vitamin B1 to Reduce Abusive Alcohol Use

Completed
NCT01868191Phase 3

Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)

Unknown
NCT00117026Phase 1

Effects of Vitamin B1 in Type 1 Diabetic Patients

Completed
NCT00565318Phase 4

Benfotiamine in Diabetic Nephropathy

Completed
NCT00785460Phase 3

Benfotiamine Prevents Vascular Dysfunction in Healthy Smokers

Completed
NCT00446810Phase 4

Chronic Treatment With Benfotiamine Restores Endothelial Function in People With Type 2 Diabetes Mellitus

Unknown

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8